There continues to be debate re: cervical cancer screening & the benefits of co-testing with respect to the risk/benefit ratio. This interview reviews the guidelines & pertinent study data as applicable to cervical cancer screening in clinical practice. Join Dr. Mark Spitzer as he reviews the information & helps to apply it to the patients in your practice. (.25 credits)
What Do the New Guidelines and Emerging Technologies Mean to Your Patients and How You Practice Medicine? This will provide clinicians with an overview of cytology-based and emerging cervical cancer screening methods (DNA and mRNA testing) for high-risk HPV.
This CME activity focuses on the minimally invasive surgical approach to AUB, patient work-up, risk management, and resectoscopic and global endometrial ablation techniques are discussed.
This examines intrauterine visualization methods; resource management methods; strategies to ensure optimal outcomes; and pathways combining diagnostic and operative hysteroscopy.
This CME activity focuses on counseling patients who are potential candidates for referral from primary care for minimally invasive gynecologic surgery.
This activity focuses the implementation of national guidelines for fluid management, likely resulting in improved procedure outcomes and increased comfort and safety.
Sharon B. Mass, MD, OBGYN and Sarah M. Friedewald, MD will discuss recent research on the value of DBT as a screening tool; current controversies in screening, eg, over-diagnosis and survival benefits; and the impact of breast density legislation.
Improve gynecologic awareness and competence in incorporating preventative/real-time remedial and safety best practices into hysteroscopic surgeries.Improve gynecologic confidence and competence when addressing operative difficulties related to hysteroscopic insertion. Increase inclusion of a pharmacologic agent that decreases operative vascularity. Increase appreciation and appropriate utilization of dilute intracervical vasopressin in patients in whom fluid overload/hyponatremia is considered a risk
This clinical minute identifies the adverse consequences of bacterial vaginosis and trichomoniasis during pregnancy. It will also describe CDC-recommended treatment guidelines for trich and bacteria vaginosis during pregnancy.
This clinical minute describes the appropriate tests for diagnosing trichomoniasis and Describe the CDC-recommended treatment guidelines for trichomoniasis.
This online CE activity was developed for nurse education and reveals advances in hysteroscopic procedures, with a focuson fluid absorption, and related knowledge and associated practice deficits.
The faculty will provide an overview of the new advances in hysteroscopic procedures with a focus on practice deficits related to managing the potential risk of complications pertaining to fluid absorption.